Peptide Decoding
New?New to peptides?Start here →
Decoding

GHRP-1_Dosage, benefits & legal status

Also known as growth hormone releasing peptide 1, GHRP1

Published August 24, 2026

The seven-amino-acid member of the family, studied early and then left behind.

Muscle & recoveryGH secretagogue (GHRP)Research only
DoseResearch only
FrequencyNot established
RouteUnder the skin (subcutaneous)
StatusResearch only
CycledNot established

Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.

See how this dose compares across the library →

01

What is GHRP-1?

Plain language first. The technical label stays, but it never stands alone.

Overview

An older cousin of GHRP-2 that never got developed. It works on the same receptor, and almost everything written about its dosing is borrowed from a different peptide.

The technical version

GHRP-1 (Ala-His-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2), a heptapeptide ghrelin receptor agonist from the Bowers GHRP series, signaling through GHSR-1a via phospholipase C. Named individually on the WADA prohibited list. Human pharmacokinetic and efficacy data is minimal compared with GHRP-2.

What it's used for

An injected peptide that signals a pulse of your own growth hormone. Rarely sold and rarely studied compared with GHRP-2 and GHRP-6.

02

How does GHRP-1 work?

What it does in the body, and where.

GHRP-1 belongs to the series Cyril Bowers built by modifying met-enkephalin, and it sits one amino acid longer than the rest.

  1. 01
    It activates the ghrelin receptor
    The same target as GHRP-2, GHRP-6, hexarelin and ipamorelin. Activation triggers a growth hormone pulse from the pituitary through a calcium-based pathway, which is different from how sermorelin and CJC-1295 work.
  2. 02
    Seven amino acids, where the others have six
    GHRP-1 is a heptapeptide. GHRP-2, GHRP-6 and hexarelin are hexapeptides. The extra residue is the clearest structural difference in the group.
  3. 03
    It was studied, and then it was not
    GHRP-1 appears in the founding literature alongside GHRP-2 and GHRP-6 and in doping-control method papers. Clinical development concentrated on GHRP-2, which reached approval in Japan as a diagnostic agent. GHRP-1 did not.
Pathway
THE PEPTIDE
GHRP-1
ACTS ON
The ghrelin receptor
RESULT
Growth hormone pulse
RESULT
Appetite and other pituitary hormones likely rise too

A schematic of the compound's mechanism, not a diagnostic image.

03

What else is it used for?

Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.

  • Raising growth hormone to build muscle and recoverResearch only
  • Diagnostic testing of pituitary growth hormone reserve, which is what the family was built forResearch only
  • Increased appetite, reported across this familyResearch only

The published record

Research index

66

Papers and trials about GHRP-1

24 papers tagged human · 17 not reviews or lab · 4 clinical trial publications

1 registered trials · none with posted results

Furthest stage reached: Phase 2, stopped early

Compare this against the whole library →

Prohibited at all times, in and out of competition. S2.2.4 Growth hormone releasing factors: GH-releasing peptides (GHRPs) (GHRP-1 named). Non-Specified.Regulators

Evidence summary

Counted from Europe PMC indexing, not read by a person; a human tag can land on reviews, commentary or lab papers; clinical trial publications is the narrower count.

GHRP-1 vial rendering
Compound field notes

At a glance

Four things to know about GHRP-1

01

Evidence

Research only

02

Category

Growth hormone

03

Common vial

Varies

04

Half-life

Nothing published

04

How much, and do you cycle it?

The range, and whether you take breaks.

Research only, not established. Not established No range

Continuous exposure to a ghrelin-receptor peptide blunts the growth hormone response to a later dose, which is documented in people for the studied members of this family. Whether that applies at the same rate to this one has not been measured, and no schedule has been compared against another.

Source: 24-hour GHRP infusion attenuates the response to a later GHRP bolus (J Clin Endocrinol Metab, 1993)

Compare this against the whole library →

05

How long does it stay in the body?

The half-life, and where the figure comes from.

Nothing publishedNo figure

No half-life has been published for this compound. What exists for the family is concentrated in GHRP-2 and GHRP-6, and those numbers belong to those molecules. Doping-control laboratories have measured how long some of these peptides remain detectable in urine, which is a different question from how long they act.

You can compare this against the whole library to see where it sits.

06

How do I dose and price it?

Enter your vial and your dose. Pick a mix. We show the draw and the cost.

The vial holds a fixed amount of drug. Adding more water does not make more drug, it just spreads it thinner, so you draw a bigger number on the syringe for the same dose.

Your vial size (mg)
Printed on the vial.
What you paid per vial
$
Used for cost per dose only.
Your dose (mcg)
Commonly referenced range: 100 up to 300 mcgCommunity practice

Choose your mix

your own mL
units · —
Enter your own volume

Measuring the water1 mL = one full 100-unit syringe.

YOUR DRAW2 / 100 units
2 units is a very small line to read, so a small slip is a large error. A larger water volume above spreads the same dose across more units.
07

How do you store it?

Before mixing, and after.

Dry powder in the freezer or fridge. Once mixed, fridge, and use within about a month.

Unmixed lyophilized GHRP-1 keeps for a long time cold. Once you add water the clock starts: most reconstituted vials hold up for roughly 28 to 30 days at fridge temperature. Keep it out of light, and do not freeze it after mixing.

08

What are the side effects and cautions?

Known cautions and warnings for this compound.
Handling note

Ghrelin-receptor peptides can cause a histamine flush: temporary flushing, itching, or welts near the injection, usually mild and short-lived. Injecting slowly helps. Spreading redness, heat, streaking, oozing or fever suggests infection and needs a doctor. Hives all over, a swollen face or throat, or trouble breathing is an allergic reaction and needs help immediately.

Solubility, computed: 43% charged residues, 71% hydrophobic. Water usually sufficient.

A first-pass rule from peptide manufacturers' guidance. It does not account for disulfide bridges, salt form or how the powder was dried, and it predicts what should be easy rather than what will happen in your vial.

Who should avoid it

Check these before anything else.
  • Active cancer, as a precaution with anything that raises growth hormone and IGF-1
  • Pregnancy or breastfeeding
  • Anyone competing in drug-tested sport
  • Anyone who wants established safety data, because none exists for this compound in humans

Stop and get help

These are emergencies. Seek care.
  • Signs of an allergic reaction, including spreading hives, facial or throat swelling, or trouble breathing
  • Redness, heat, or pus at the injection site, which can signal infection
  • Persistent milky nipple discharge, which can indicate raised prolactin
  • Anything unusual, since there is no known safety profile to compare it against

Common effects

Expected, and usually mild.
  • Unknown. No study has recorded what this compound commonly causes in people
  • Redness, soreness, or a small bump at the injection site
  • Increased hunger, reported across this family of peptides

Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.

09

Is GHRP-1 approved?

And where the numbers on this page come from.

No. GHRP-1 is not approved for any use, anywhere. It is sold labeled for laboratory research only, and there is no legal route to buy it for human use.

  • Approval status
    Research only
  • Route
    Under the skin (subcutaneous)
  • Checked
    24 August 2026
  • Dose
    From community reports. No regulator or trial established this dose.
  • Vial size
    From what vendors typically list; not a recommendation.
  • Sources
    None traced yet.

What has happened recently

Not approved for any medical use anywhere. Prohibited in sport at all times by WADA, which names GHRP-1 through GHRP-6 individually under section S2.

What regulators say

From official documents

Banned in drug-tested sport. Most research peptides are prohibited under WADA's S0 category, which covers any substance with no approval from any regulatory authority for human use. That means a compound can be banned without ever being named on the prohibited list. Check with your own anti-doping authority rather than assuming absence from the list means permitted.

You can compare this against the whole library, or read how to check a seller.

Guides for this compound

Sources

No primary source has been traced for this compound yet. Treat everything on this page as unverified until one is. How we grade evidence

Beyond these, 66 records are indexed. Browse the records